Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants

Gillian Caughey, Elizabeth Ellen Roughead, Sepehr Shakib, Robyn A. McDermott, Agnes Vitry, Andrew L. Gilbert

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objectives: the study aimed to examine the prevalence of comorbidity, the prescribing of potentially inappropriate medications and treatment conflicts in a large sample of older people who have been dispensed an antidepressant medicine. Methods: a cross-sectional study of administrative claims data from the Department of Veterans' Affairs, Australia, 1 April-31 July 2007, of veterans aged ≥65 years was conducted. Comorbidities determined using the pharmaceutical-based comorbidity index, Rx-Risk-V. Concomitant medicines that may be potentially inappropriate for patients with depression and areas of treatment conflicts were determined from Australian clinical guidelines or reference compendia. Results: a total of 39,695 subjects were included, with a median of 5 comorbid conditions (inter-quartile range 3-6). Ninety percent of medicine use was attributed to the treatment of comorbid conditions. Eighty-seven percent of the study cohort was identified as having at least one comorbid condition that may cause a potential treatment conflict when an antidepressant is used. Those conditions of most concern included cardiovascular diseases, anxiety disorders, arthritis or pain management and osteoporosis. Conclusion: we observed a high level of potentially inappropriate prescribing and treatment conflicts that may arise when caring for older patients dispensed an antidepressant with comorbidity. These have the potential to place a large number of older people with depression at increased risk for adverse events.

LanguageEnglish
Article numberafq055
Pages488-494
Number of pages7
JournalAge and Ageing
Volume39
Issue number4
DOIs
Publication statusPublished - 27 May 2010
Externally publishedYes

Keywords

  • Antidepressant
  • Chronic disease
  • Comorbidity
  • Depression
  • Elderly

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Cite this

Caughey, Gillian ; Roughead, Elizabeth Ellen ; Shakib, Sepehr ; McDermott, Robyn A. ; Vitry, Agnes ; Gilbert, Andrew L. / Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. In: Age and Ageing. 2010 ; Vol. 39, No. 4. pp. 488-494.
@article{01c0e534d13244d3bc2c1b0c144ba9de,
title = "Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants",
abstract = "Objectives: the study aimed to examine the prevalence of comorbidity, the prescribing of potentially inappropriate medications and treatment conflicts in a large sample of older people who have been dispensed an antidepressant medicine. Methods: a cross-sectional study of administrative claims data from the Department of Veterans' Affairs, Australia, 1 April-31 July 2007, of veterans aged ≥65 years was conducted. Comorbidities determined using the pharmaceutical-based comorbidity index, Rx-Risk-V. Concomitant medicines that may be potentially inappropriate for patients with depression and areas of treatment conflicts were determined from Australian clinical guidelines or reference compendia. Results: a total of 39,695 subjects were included, with a median of 5 comorbid conditions (inter-quartile range 3-6). Ninety percent of medicine use was attributed to the treatment of comorbid conditions. Eighty-seven percent of the study cohort was identified as having at least one comorbid condition that may cause a potential treatment conflict when an antidepressant is used. Those conditions of most concern included cardiovascular diseases, anxiety disorders, arthritis or pain management and osteoporosis. Conclusion: we observed a high level of potentially inappropriate prescribing and treatment conflicts that may arise when caring for older patients dispensed an antidepressant with comorbidity. These have the potential to place a large number of older people with depression at increased risk for adverse events.",
keywords = "Antidepressant, Chronic disease, Comorbidity, Depression, Elderly",
author = "Gillian Caughey and Roughead, {Elizabeth Ellen} and Sepehr Shakib and McDermott, {Robyn A.} and Agnes Vitry and Gilbert, {Andrew L.}",
year = "2010",
month = "5",
day = "27",
doi = "10.1093/ageing/afq055",
language = "English",
volume = "39",
pages = "488--494",
journal = "Age and Ageing",
issn = "0002-0729",
publisher = "Oxford University Press",
number = "4",

}

Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. / Caughey, Gillian; Roughead, Elizabeth Ellen; Shakib, Sepehr; McDermott, Robyn A.; Vitry, Agnes; Gilbert, Andrew L.

In: Age and Ageing, Vol. 39, No. 4, afq055, 27.05.2010, p. 488-494.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants

AU - Caughey, Gillian

AU - Roughead, Elizabeth Ellen

AU - Shakib, Sepehr

AU - McDermott, Robyn A.

AU - Vitry, Agnes

AU - Gilbert, Andrew L.

PY - 2010/5/27

Y1 - 2010/5/27

N2 - Objectives: the study aimed to examine the prevalence of comorbidity, the prescribing of potentially inappropriate medications and treatment conflicts in a large sample of older people who have been dispensed an antidepressant medicine. Methods: a cross-sectional study of administrative claims data from the Department of Veterans' Affairs, Australia, 1 April-31 July 2007, of veterans aged ≥65 years was conducted. Comorbidities determined using the pharmaceutical-based comorbidity index, Rx-Risk-V. Concomitant medicines that may be potentially inappropriate for patients with depression and areas of treatment conflicts were determined from Australian clinical guidelines or reference compendia. Results: a total of 39,695 subjects were included, with a median of 5 comorbid conditions (inter-quartile range 3-6). Ninety percent of medicine use was attributed to the treatment of comorbid conditions. Eighty-seven percent of the study cohort was identified as having at least one comorbid condition that may cause a potential treatment conflict when an antidepressant is used. Those conditions of most concern included cardiovascular diseases, anxiety disorders, arthritis or pain management and osteoporosis. Conclusion: we observed a high level of potentially inappropriate prescribing and treatment conflicts that may arise when caring for older patients dispensed an antidepressant with comorbidity. These have the potential to place a large number of older people with depression at increased risk for adverse events.

AB - Objectives: the study aimed to examine the prevalence of comorbidity, the prescribing of potentially inappropriate medications and treatment conflicts in a large sample of older people who have been dispensed an antidepressant medicine. Methods: a cross-sectional study of administrative claims data from the Department of Veterans' Affairs, Australia, 1 April-31 July 2007, of veterans aged ≥65 years was conducted. Comorbidities determined using the pharmaceutical-based comorbidity index, Rx-Risk-V. Concomitant medicines that may be potentially inappropriate for patients with depression and areas of treatment conflicts were determined from Australian clinical guidelines or reference compendia. Results: a total of 39,695 subjects were included, with a median of 5 comorbid conditions (inter-quartile range 3-6). Ninety percent of medicine use was attributed to the treatment of comorbid conditions. Eighty-seven percent of the study cohort was identified as having at least one comorbid condition that may cause a potential treatment conflict when an antidepressant is used. Those conditions of most concern included cardiovascular diseases, anxiety disorders, arthritis or pain management and osteoporosis. Conclusion: we observed a high level of potentially inappropriate prescribing and treatment conflicts that may arise when caring for older patients dispensed an antidepressant with comorbidity. These have the potential to place a large number of older people with depression at increased risk for adverse events.

KW - Antidepressant

KW - Chronic disease

KW - Comorbidity

KW - Depression

KW - Elderly

UR - http://www.scopus.com/inward/record.url?scp=77954262676&partnerID=8YFLogxK

U2 - 10.1093/ageing/afq055

DO - 10.1093/ageing/afq055

M3 - Article

VL - 39

SP - 488

EP - 494

JO - Age and Ageing

T2 - Age and Ageing

JF - Age and Ageing

SN - 0002-0729

IS - 4

M1 - afq055

ER -